Fingerprint
Dive into the research topics of 'Natalizumab in Crohn's disease: Results from a US tertiary inflammatory bowel disease center'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Natalizumab in Crohn's disease: Results from a US tertiary inflammatory bowel disease center
Atsushi Sakuraba, Kian Keyashian, Chase Correia, John Melek, Russell D. Cohen, Stephen B. Hanauer, David T. Rubin
Research output: Contribution to journal › Article › peer-review
35
Scopus
citations